New England Asset Management’s CVS Health CVS Stock Holding History

New England Asset Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.07M	Hold	98,480	–	–	0.9%	33
2025 Q4	$7.82M	Buy	98,480 +2,790	+3%	+$220K	1.02%	24
2025 Q3	$7.21M	Buy	95,690 +540	+0.6%	+$37K	0.94%	29
2025 Q2	$6.56M	Buy	95,150 +415	+0.4%	+$27.2K	1.02%	32
2025 Q1	$6.42M	Buy	94,735 +8,265	+10%	+$495K	1.04%	32
2024 Q4	$3.88M	Sell	86,470 -10,255	-11%	-$575K	0.66%	57
2024 Q3	$6.08M	Sell	96,725 -500	-0.5%	-$29.2K	0.95%	37
2024 Q2	$5.74M	Buy	97,225 +16,445	+20%	+$1.03M	0.95%	37
2024 Q1	$6.44M	Buy	80,780 +3,330	+4%	+$254K	1%	33
2023 Q4	$6.12M	Sell	77,450 -5,950	-7%	-$423K	0.98%	35
2023 Q3	$5.82M	Sell	83,400 -6,046	-7%	-$428K	0.96%	39
2023 Q2	$6.18M	Hold	89,446	–	–	0.9%	40
2023 Q1	$6.65M	Buy	89,446 +47,700	+114%	+$4M	0.99%	35
2022 Q4	$3.89M	Buy	41,746 +21,950	+111%	+$2.12M	0.07%	59
2022 Q3	$1.89M	Hold	19,796	–	–	0.03%	86
2022 Q2	$1.83M	Buy	19,796 +750	+4%	+$73.2K	0.03%	86
2022 Q1	$1.93M	Sell	19,046 -385	-2%	-$40.4K	0.03%	89
2021 Q4	$2M	Sell	19,431 -1,600	-8%	-$148K	0.03%	85
2021 Q3	$1.78M	Hold	21,031	–	–	0.03%	88
2021 Q2	$1.75M	Hold	21,031	–	–	0.03%	87
2021 Q1	$1.58M	Hold	21,031	–	–	0.03%	89
2020 Q4	$1.44M	Hold	21,031	–	–	0.03%	88
2020 Q3	$1.23M	Buy	21,031 +100	+0.5%	+$6.22K	0.03%	89
2020 Q2	$1.36M	Hold	20,931	–	–	0.03%	86
2020 Q1	$1.24M	Buy	20,931 +500	+2%	+$33.4K	0.03%	84
2019 Q4	$1.52M	Hold	20,431	–	–	0.02%	94
2019 Q3	$1.29M	Hold	20,431	–	–	0.02%	96
2019 Q2	$1.11M	Hold	20,431	–	–	0.02%	103
2019 Q1	$1.1M	Buy	20,431 +1,400	+7%	+$86.4K	0.02%	104
2018 Q4	$1.25M	Sell	19,031 -893	-4%	-$66.7K	0.03%	92
2018 Q3	$1.57M	Hold	19,924	–	–	0.03%	87
2018 Q2	$1.28M	Sell	19,924 -4,900	-20%	-$323K	0.02%	92
2018 Q1	$1.54M	Sell	24,824 -1,000	-4%	-$71.7K	0.03%	89
2017 Q4	$1.87M	Sell	25,824 -2,600	-9%	-$189K	0.04%	75
2017 Q3	$2.31M	Hold	28,424	–	–	0.05%	65
2017 Q2	$2.29M	Sell	28,424 -4,200	-13%	-$332K	0.07%	58
2017 Q1	$2.56M	Buy	32,624 +200	+0.6%	+$16K	0.04%	63
2016 Q4	$2.56M	Sell	32,424 -700	-2%	-$56.6K	0.07%	48
2016 Q3	$2.95M	Buy	33,124 +1,800	+6%	+$170K	0.11%	38
2016 Q2	$3M	Sell	31,324 -700	-2%	-$69.8K	0.11%	34
2016 Q1	$3.32M	Hold	32,024	–	–	0.1%	32
2015 Q4	$3.13M	Sell	32,024 -12,900	-29%	-$1.26M	0.08%	35
2015 Q3	$4.33M	Sell	44,924 -6,600	-13%	-$694K	0.11%	34
2015 Q2	$5.4M	Sell	51,524 -1,533	-3%	-$157K	0.13%	32
2015 Q1	$5.48M	Buy	53,057 +10,857	+26%	+$1.1M	0.13%	34
2014 Q4	$4.07M	Sell	42,200 -64,632	-60%	-$5.69M	0.1%	37
2014 Q3	$8.5M	Sell	106,832 -3,600	-3%	-$284K	0.21%	34
2014 Q2	$8.32M	Buy	110,432 +4,600	+4%	+$348K	0.2%	33
2014 Q1	$7.92M	Sell	105,832 -100	-0.1%	-$7.06K	0.2%	31
2013 Q4	$7.58M	Sell	105,932 -700	-0.7%	-$45K	0.2%	37
2013 Q3	$6.05M	Buy	106,632 +3,000	+3%	+$179K	0.18%	43
2013 Q2	$5.93M	Buy	+103,632	New	+$6M	0.18%	43

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

New England Asset Management's CVS Position: Q1 2026 in Review

New England Asset Management held its CVS Health (CVS) position steady in Q1 2026 at 98,480 shares worth $7.07M. The position accounts for 0.9% of the portfolio, ranked #33.

New England Asset Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.5M in Q3 2014. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

New England Asset Management held 98,480 shares of CVS Health worth $7.07M as of Q1 2026.
New England Asset Management left its CVS Health share count unchanged in Q1 2026.
CVS Health made up 0.9% of New England Asset Management's portfolio in Q1 2026, its #33 holding.
New England Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
New England Asset Management's CVS Health position peaked at $8.5M in Q3 2014.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on New England Asset Management's 13F filing for Q1 2026, filed 15 May 2026.